NCT06127394

Efficacy of Sacral Erector Spinae Plane Block (SESPB) on Postoperative Pain and Catheter-related Bladder Discomfort

Comparison of the Efficacy of Sacral Erector Spinae Plane Block (SESPB) and Pudendal Block on Postoperative Pain and Catheter-related Bladder Discomfort (CRBD) in Patients Undergoing Trans-urethral Resection of the Prostate (TUR-P).
Giresun University·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Pain, Postoperative
Drug/Device/Intervention
Sacral ESP Block
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Giresun University
Location
Merkez, Turkey
Timeline & enrollment
Phase
N/A
Start date
Nov 12, 2023
End date
Jan 15, 2024
Enrollment
54 participants
Primary outcome

Catheter related bladder discomfort, 0:no discomfort 4:worst discomfort

Summary

The goal of this clinical trial is to evaluate the catheter related bladder discomfort in
 patients who will undergoing TUR-P operation. The main questions it aims to answer are:
 
 - Is sacral ESPB effective on the pudendal nerve dermatome?
 
 - Is sacral ESPB as useful as pudendal block on CRBD? Participants will be divided into
 two groups and the first group will receive sacral espb after TUR-p operation and the
 second group will receive pudendal block. Investigators will be present for 24 hours
 
 - catheter related bladder discomfort
 
 - post-operative pain,
 
 - additional analgesic needs will be questioned and the difference between the two
 groups will be evaluated.

ICD-10 classifications
During surgical operationDuring surgical operationDuring surgical operationPain, unspecifiedPostoperative intestinal obstruction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06127394
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06127394 through Pure Global AI's free database. This phase not specified trial is sponsored by Giresun University and is currently Recruiting. The study focuses on Pain, Postoperative. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.